Literature DB >> 35891309

Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Stephanie James1, Robert C Haight2, Cassandra Hanna2, Lindsey Furton3.   

Abstract

Down syndrome is caused by an extra copy of chromosome 21. In the past two decades, the life expectancy of individuals with Down syndrome has significantly increased from early 20s to early 60s, creating a population of individuals of which little is known about how well they are protected against infectious disease. The goal of this work is to better understand if adults with Down syndrome are well protected against influenza following vaccination. We obtained plasma samples from 18 adults (average age = 31yo) with Down syndrome and 17 age/gender-matched disomic individuals, all vaccinated against influenza. Antibody concentration to influenza A was measured using ELISA and antibody titers were measured using a hemagglutinin inhibition assay. Statistical analysis was performed using Stata Statistical Software. Adults with Down syndrome had a significantly increased concentration of antibodies to a mixture of influenza A viral proteins; however, they had a significantly decreased titer to the Influenza A/Hong Kong compared to disomic controls. These findings suggest that more vigorous studies of B- and T-cell function in adults with Down syndrome with respect to influenza vaccination are warranted, and that this population may benefit from a high-dose influenza vaccine.

Entities:  

Keywords:  Down syndrome; Trisomy 21; influenza; vaccine

Year:  2022        PMID: 35891309      PMCID: PMC9324516          DOI: 10.3390/vaccines10071145

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  29 in total

1.  Epidemiology of Down syndrome (Trisomy 21), Hawaii, 1986-97.

Authors:  Mathias B Forrester; Ruth D Merz
Journal:  Teratology       Date:  2002-05

2.  Morbidity and hospitalizations of adults with Down syndrome.

Authors:  Ariel Tenenbaum; Maor Chavkin; Isaiah D Wexler; Maya Korem; Joav Merrick
Journal:  Res Dev Disabil       Date:  2011-12-01

Review 3.  The immunology of influenza virus-associated bacterial pneumonia.

Authors:  Keven M Robinson; Jay K Kolls; John F Alcorn
Journal:  Curr Opin Immunol       Date:  2015-02-24       Impact factor: 7.486

4.  Current estimate of Down Syndrome population prevalence in the United States.

Authors:  Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

5.  Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?

Authors:  Noortje B Eijsvoogel; Mirjam I Hollegien; Vinus L A Bok; Arda G Derksen Lubsen; Felix P J Dikken; Sander A C A P Leenders; Arjan Pijning; Erica Post; Marek Wojciechowski; Mirrian Hilbink; Esther de Vries
Journal:  J Med Virol       Date:  2017-05-02       Impact factor: 2.327

Review 6.  Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21).

Authors:  L B Epstein; R Philip
Journal:  Prog Clin Biol Res       Date:  1987

7.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

Review 8.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

9.  Increased systemic inflammation in children with Down syndrome.

Authors:  Dean Huggard; Lynne Kelly; Emer Ryan; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; T Ronan Leahy; Orla Franklin; Derek G Doherty; Eleanor J Molloy
Journal:  Cytokine       Date:  2019-11-27       Impact factor: 3.861

10.  Mortality and cancer incidence among individuals with Down syndrome.

Authors:  Deirdre A Hill; Gloria Gridley; Sven Cnattingius; Lene Mellemkjaer; Martha Linet; Hans-Olof Adami; Jorgen H Olsen; Olof Nyren; Joseph F Fraumeni
Journal:  Arch Intern Med       Date:  2003-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.